Watchlist Price Alert

Addex Therapeutics Ltd (ADXN)

NASDAQ: ADXN · Real-Time Price · USD

8.25

-0.13 (-1.59%)

At close: Jun 16, 2025, 1:40 PM

Addex Therapeutics Ltd Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.34M	3.87M	6.96M	20.48M	18.7M	31.54M	41.67M	2.59M	1.42M
Short-Term Investments	6.5K	848.00	3.17K	17.14K	64.93K	13.97K	7.98K	n/a	n/a
Long-Term Investments	7.09M	n/a	n/a	n/a	n/a	n/a	54.4K	7.09K	7.1K
Other Long-Term Assets	7.09K	54.34K	54.35K	57.91K	59.14K	68.91K	n/a	n/a	n/a
Receivables	15.51K	151.27K	598.32K	324.42K	68.37K	118.03K	273.02K	303.88K	220.72K
Inventory	n/a	n/a	-871.6M	n/a	162.84K	-13.97K	n/a	n/a	n/a
Other Current Assets	7.97K	n/a	n/a	n/a	162.84K	n/a	n/a	n/a	n/a
Total Current Assets	3.54M	4.23M	7.83M	21.94M	19.49M	32.39M	42.15M	3.05M	1.66M
Property-Plant & Equipment	42.71K	352.94K	398.73K	542.1K	633.1K	570.97K	8.87K	2.75K	17.3K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.14M	407.28K	453.09K	600.01K	692.25K	639.88K	63.27K	9.84K	24.41K
Total Assets	10.68M	4.64M	8.28M	22.54M	20.18M	33.03M	42.21M	3.06M	1.68M
Account Payables	253.29K	984.38K	1.28M	1.79M	983.54K	2.22M	1.15M	383.21K	669.68K
Deferred Revenue	n/a	n/a	n/a	n/a	820.15K	1.11M	212.74K	439.02K	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	234.98K	n/a	n/a	n/a	n/a	n/a	439.02K	n/a
Total Current Liabilities	802.09K	2.89M	3.28M	4.13M	3.62M	5.68M	2.33M	1.48M	1.25M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	164.25K	532.76K	n/a	1.28M	1.69M	1.65M	639.35K	243.86K	214.44K
Total Long-Term Liabilities	198.94K	603.14K	87.03K	1.48M	1.95M	1.82M	639.35K	243.86K	214.44K
Total Liabilities	1M	3.5M	3.37M	5.61M	5.57M	7.5M	2.97M	1.72M	1.46M
Total Debt	41.99K	344.34K	373.13K	482.01K	567.4K	550.25K	n/a	n/a	n/a
Common Stock	1.84M	1.84M	1.15M	49.27M	32.85M	32.85M	28.56M	13.42M	11.56M
Retained Earnings	-353.36M	-360.42M	-349.86M	-329.06M	-313.71M	-300.85M	-286.07M	-284.42M	-281.14M
Comprehensive Income	31.06M	29.81M	25.77M	24.44M	8.58M	7.15M	10.27M	7.55M	6.76M
Shareholders Equity	9.68M	1.15M	4.91M	16.93M	14.61M	25.52M	39.24M	1.34M	218.59K
Total Investments	7.09M	848.00	3.17K	17.14K	64.93K	13.97K	7.98K	7.09K	7.1K